00:00 / 00:00
Information for patients and families
Glut1 deficiency syndrome (Glut1 Deficiency Foundation)
Gorlin syndrome (Gorlin Syndrome Alliance)
Recurrent pericarditis (NORD)
Autoimmune polyglandular syndrome type 1 (NORD)
Opsoclonus myoclonus syndrome (NORD)
Thyroid eye disease (NORD)
Bile synthesis disorders (NORD)
Cyclic vomiting syndrome (NORD)
Eosinophilic esophagitis (NORD)
Short bowel syndrome (NORD)
Essential thrombocythemia (NORD)
Myelofibrosis (NORD)
Polycythemia vera (NORD)
Sickle cell disease (NORD)
Waldenstrom macroglobulinemia (NORD)
Warm autoimmune hemolytic anemia and cold agglutinin (NORD)
Congenital athymia (NORD)
Cytomegalovirus infection after transplant (NORD)
Post-transplant lymphoproliferative disorders (NORD)
Severe chronic neutropenia (NORD)
Adrenoleukodystrophy (NORD)
Alagille syndrome (NORD)
Aromatic L-amino acid decarboxylase deficiency (NORD)
Cerebrotendinous xanthomatosis (NORD)
Classical homocystinuria (NORD)
Congenital cytomegalovirus (NORD)
Cystinuria (NORD)
Fabry disease (NORD)
Gaucher disease (NORD)
Glycogen storage disease type II (NORD)
Metachromatic leukodystrophy (NORD)
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Mycobacterium avium complex (NORD)
NGLY1 deficiency (NORD)
Niemann-Pick disease types A and B (NORD)
Phenylketonuria (NORD)
PIK3CA-related overgrowth spectrum (NORD)
Tay-Sachs disease (NORD)
Zellweger spectrum disorders (NORD)
Early infantile epileptic encephalopathy (NORD)
Opsoclonus myoclonus syndrome (NORD)
Spinocerebellar ataxia (NORD)
Narcolepsy (NORD)
Focal segmental glomerulosclerosis (NORD)
IgA nephropathy (NORD)
Pulmonary arterial hypertension (NORD)
ADHD: Information for patients and families (The Primary School)
Asthma: Information for patients and families (The Primary School)
Childhood nutrition and obesity: Information for patients and families (The Primary School)
Childhood oral health: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Toxic stress: Information for patients and families (The Primary School)
NGLY1 deficiency is a rare genetic disorder affecting multiple parts of the body due to a deficiency of the enzyme N-glycanase.
Enzymes are proteins which help speed up chemical reactions in the body and N-glycanase speeds up the removal of sugar chains from proteins.
Without this process, proteins do not function normally and misshaped ones may accumulate. NGLY1 deficiency is a chronic condition that presents during infancy and early childhood.
NGLY1 deficiency has a number of characteristic symptoms, although the specific symptoms a patient experiences are often unique to the individual.
Most infants and children with NGLY1 deficiency do not grow or develop as expected. Symptoms may include low birthweight, a smaller than expected head circumference, and missing developmental milestones, such as walking or talking.
Intellectual disability is also common. Many affected individuals have motor problems including shaking and uncontrollable movements, which can range from slight tremors while trying to do fine motor skills like writing, to an uncontrolled sometimes painful jerky movement.
Skeletal abnormalities may also occur such as small hands or feet, frequently broken bones, uneven shoulders or hips, difficulty standing up straight, and dislocated joints.
Some patients develop seizures which can start as early as two months of age. Individuals with NGLY1 deficiency often will not produce tears when crying.
This in turn may cause other complications, such as scarring and ulcers in the eyes, painful or irritated eyes, and poor vision. Lastly, liver problems may arise in children with NGLY1 deficiency.
NGLY1 deficiency is caused by changes or mutations in the NGLY1 gene, and follows an autosomal recessive inheritance pattern.
This means that both copies of the NGLY1 gene must be mutated for an individual to have the disorder. The mutated NGLY1 gene causes the N-glycanase enzyme to be dysfunctional or be completely absent.
N-glycanase 1 deficiency, also known as NGLY1 deficiency, is a rare genetic disorder characterized by a deficiency of the enzyme N-glycanase 1 (NGLY1). NGLY1 is involved in the breakdown of complex sugars known as N-glycans attached to proteins throughout the body.
NGLY1 deficiency results from a mutation in the NGLY1 gene that decreases NGLY1 production. Symptoms include developmental delays, intellectual disability, seizures, delayed developmental milestones, as well as problems with movement and coordination. They may also have abnormalities of the eyes, including cataracts and problems with eye movement.
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.